Skip to main content
Journal ArticleOPEN ACCESS

Acute kidney injury in a patient on tenofovir alafenamide fumarate after initiation of treatment for hepatitis C virus infection

Open Forum Infectious Diseases (2018) 5(8)
DOI: 10.1093/ofid/ofy189
14Citations
Citations of this article
21Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

HIV treatment with tenofovir alafenamide fumarate (TAF) has decreased renal toxicity compared with tenofovir disoproxil fumarate in clinical trials. We report the case of a patient with HIV/HCV coinfection who was started on a TAF-based HIV regimen and developed acute kidney injury that worsened with the addition of sofosbuvir-ledipasvir.

Author supplied keywords

Cite

CITATION STYLE

APA

Serota, D. P., Franch, H. A., & Cartwright, E. J. (2018). Acute kidney injury in a patient on tenofovir alafenamide fumarate after initiation of treatment for hepatitis C virus infection. Open Forum Infectious Diseases, 5(8). https://doi.org/10.1093/ofid/ofy189

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free